Contains the active ingredient furosemide frusemide. What is in this leaflet This leaflet answers some common questions about this medicine. It does not take the place of talking to your doctor or ...

Patients were safely able to return home and receive the diuretic by minipump, minimizing their time spent at the hospital.

SUBCUT HF II, a randomized controlled investigator-sponsored trial of at-home subcutaneous furosemide for heart failure–related edema, meets its primary and key secondary endpoints, supporting the ...

Company’s furosemide tablets were found to be bioequivalent and have the same therapeutic effect as Aventis’ Lasix tablets The Office of Generic Drugs, FDA, granted Ranbaxy Laboratories (RLL) approval ...

SQ Innovation today announced that results of the SUBCUT HF II trial of its product Lasix® ONYU, will be presented at Heart Failure 2026, the annual congress of the Heart Failure Association (HFA) of ...

A Prescription Drug User Fee Act target date of July 26, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application ...